Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000412336) titled 'MiSaver Cell Injection for Heart Attack : Safety and Efficacy Study of Cells derived from Umbilical Cord Blood' on April 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Type of endpoint: Safety/efficacy
Primary Sponsor: HONYA Medical Co Ltd
Condition:
Acute Myocardial Infarction
Acute Myocardial Infarction
Cardiovascular - Coronary heart disease
Intervention:
This is a prospective, single-blind, randomized, placebo-controlled, parallel-group, multi-center, multi-region study evaluating the safety, efficacy, and dose ...